Results 121 to 130 of about 11,990 (178)

Burkholderia cepacia Endocarditis in a Patient With Severe Mitral Annular Calcification. [PDF]

JACC Case Rep
Pepe V, Afari H, O'Quinn RP, Arjoon R.
europepmc   +1 more source

Activity of antibiotics against Burkholderia cepacia complex in artificial sputum medium. [PDF]

J Antimicrob Chemother
Shukla A, Rodriguez S, Brennan-Krohn T.
europepmc   +1 more source

The First Case of a Cat Infected with Burkholderia pseudomultivorans, a Member of the Burkholderia cepacia Complex. [PDF]

Vet Sci
Fujii Y, Suwa A, Tsuyuki Y, Koyama K, Nio-Kobayashi J, Yoshii K.   +5 more
europepmc   +1 more source

Burkholderia cepacia Infective Endocarditis of Native Aortic Valve: A Case Report and Review of Literature. [PDF]

Cureus
Almubarak I, Almubarak AJ, Ahmed YA, Ali MA, Yusuf WH, Ismail M, Elhadidi S, Abdelaziz H, Gabr MA, Awad G.   +9 more
europepmc   +1 more source

Evaluation of antimicrobial susceptibility testing methods for Burkholderia cepacia complex isolates from people with and without cystic fibrosis. [PDF]

J Clin Microbiol
Jorth P, Manuel C, McLemore T, Humphries RM, Cole NC, Schuetz AN, Garica D, Maldonado M, Rivero N, Milesi Galdino AC, Celedonio D, LiPuma JJ, Green DA, Zlosnik JEA, Traczewski M, Huse HK.   +15 more
europepmc   +1 more source

Identification of Burkholderia cepacia Complex: Comparing Conventional, Automated, and Molecular Methods in a Tertiary Care Center. [PDF]

Cureus
Periaiah P, Antony T, Samuel S.
europepmc   +1 more source

Dynamics understanding of novel solvated drug molecules against emerging <i>Burkholderia Cepacia</i> infections in immunocompromised patients.

Results Chem
Ahmad S, Ahmad F, Abideen SA, Khan K, Irfan M, Siddique F, Albekairi NA, Alshammari AM, Wei DQ.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Burkholderia cepacia: This Decision Is Overdue

PDA Journal of Pharmaceutical Science and Technology, 2011
This is the third in a series of seven articles discussing the Recall Root Cause Research project conducted by the Division of Manufacturing and Product Quality, Center for Drug Evaluation and Research. This paper reviews the regulatory and scientific impact of a common and recurring opportunistic pathogen, Burkholderia cepacia. B. cepacia is comprised
Lynn, Torbeck, Diane, Raccasi, Dennis E, Guilfoyle, Richard L, Friedman, David, Hussong   +4 more
openaire   +2 more sources

Lipopolysaccharide chemotypes of Burkholderia cepacia

Journal of Medical Microbiology, 1999
Burkholderia cepacia is an important pathogen in patients with cystic fibrosis (CF) and much is now known of its epidemiology. In contrast, its virulence mechanisms are poorly understood. The lipopolysaccharide (LPS) of B. cepacia, a well-recognised virulence factor of other gram-negative bacteria, is known to be strongly endotoxic in vitro. The aim of
Elwyn, Evans, Ian R, Poxton, John R W, Govan   +2 more
openaire   +2 more sources

Advances in Burkholderia cepacia complex

Paediatric Respiratory Reviews, 2002
Burkholderia cepacia is an important opportunistic pathogen in certain compromised hosts, particularly those with either cystic fibrosis (CF) or chronic granulomatous disease. The "family" of bacteria known as B. cepacia is highly heterogeneous and is composed of at least nine discrete species or genomovars, constituting the B.
openaire   +2 more sources